Full-Time

Sales Consultant

Confirmed live in the last 24 hours

Zeiss

Zeiss

1,001-5,000 employees

Corporate venture capital for deep-tech startups

No salary listed

Senior, Expert

Kolkata, West Bengal, India

In Person

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Requirements
  • Must be a graduate in science, pharmacy, or optometry
  • 8-12 years of previous successful sales experience in the Pharmaceutical / Healthcare Industry is required
  • Experience in the Optical/Ophthalmology industry preferred
Responsibilities
  • Accountable for assigned territory, meeting ophthalmologists and opticians on a regular basis, and meeting revenue budgets in line with team/organizational goals
  • Collaborate with sales teams from various locations to generate revenues in the Hospital Retail Channel
  • Carry out customer/market development efforts in collaboration with line managers
  • Manage and continually updates a client base of consultant ophthalmologists, institutions, and hospitals, and review the list to improve the business
  • Conduct product conversations with ophthalmologists, as well as consumer education, retail audits, and monitor distributor
  • Implement the company's marketing strategies on a regular basis, thereby meeting sales targets and product volume budgets
  • Meets the company's call average and ophthalmology criteria in the designated region
  • Adhere to reporting procedures, work schedules, and budgets in order to maximize sales and establish efficient sales processes
Desired Qualifications
  • Experience in the Optical/Ophthalmology industry preferred

ZEISS Ventures invests in early-stage deep-tech startups that align with the core business areas of the ZEISS Group, which specializes in optics and optoelectronics. The firm typically invests between $1 million and $5 million in companies at the pre-Series A and Series A funding stages. ZEISS Ventures focuses on four main sectors: Information Technology, Industrial Tech, MedTech, and Life Sciences. Unlike many other venture capital firms, ZEISS Ventures not only provides financial support but also offers tailored funding solutions and access to the extensive network and expertise of the ZEISS Group. The goal of ZEISS Ventures is to identify and nurture emerging businesses that can develop new technologies and business models, ultimately enhancing the ZEISS Group's existing portfolio and driving future growth.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$39.8M

Headquarters

Oberkochen, Germany

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in AI-driven pathology solutions boosts MedTech investment opportunities.
  • Semiconductor yield improvement technologies align with ZEISS's industrial tech focus.
  • Advancements in surgical precision and safety align with ZEISS's MedTech interests.

What critics are saying

  • Competition in AI-based digital pathology could challenge ZEISS's MedTech investments.
  • Rapid advancements in semiconductor tech may pressure ZEISS to innovate quickly.
  • Niche MedTech startups could disrupt traditional markets and challenge ZEISS investments.

What makes Zeiss unique

  • ZEISS Ventures focuses on deep-tech startups in optics and optoelectronics.
  • The firm invests in early-stage companies, primarily pre-Series A and Series A rounds.
  • ZEISS leverages its extensive network and expertise to support portfolio companies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

Tech.eu
Jun 26th, 2025
LIDROTEC lands $13.5M to tackle semiconductor yield bottlenecks

The German startup’s fluid-cooled laser tech targets yield gains and damage reduction in semiconductor manufacturing.

Finsmes
May 27th, 2025
Surgify Medical Raises €7M in Series A Funding

Surgify Medical, an Espoo, Finland-based medical technology company which specializes in bone surgery, raised €7M in Series A funding

Vision Monday
Oct 1st, 2024
Carl Zeiss AG Names Andreas Pecher as President and CEO, Effective April 2025

Thus, Dr. Frank Rohmund was appointed a member of the executive board and head of the Zeiss Semiconductor Manufacturing Technology (SMT) segment effective January 1, 2025, the announcement said.

Business Wire
Oct 1st, 2024
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology

Mindpeak, the leader in AI-powered pathological solutions, today announced it has raised $15.3 million in a Series A funding round. The round was led

Metrology News
Jul 8th, 2024
Enhanced PMI Library Improves CMM Productivity

ZEISS is releasing a new version of the standard software for measuring technology on the market: ZEISS CALYPSO 2024 with many new features and improvements for different user groups.